These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756 [TBL] [Abstract][Full Text] [Related]
7. The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice. Tabata C; Tabata R; Nakano T Clin Exp Immunol; 2010 Dec; 162(3):560-7. PubMed ID: 20846163 [TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of ginsan on TGF-β mediated fibrotic process. Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375 [TBL] [Abstract][Full Text] [Related]
9. Dual roles of IL-4 in lung injury and fibrosis. Huaux F; Liu T; McGarry B; Ullenbruch M; Phan SH J Immunol; 2003 Feb; 170(4):2083-92. PubMed ID: 12574379 [TBL] [Abstract][Full Text] [Related]
10. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis. Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419 [TBL] [Abstract][Full Text] [Related]
11. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6. Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275 [TBL] [Abstract][Full Text] [Related]
12. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma. Kim JH; Kim HY; Kim S; Chung JH; Park WS; Chung DH Am J Pathol; 2005 Nov; 167(5):1231-41. PubMed ID: 16251408 [TBL] [Abstract][Full Text] [Related]
13. Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice. Liu W; Wan J; Han JZ; Li C; Feng DD; Yue SJ; Huang YH; Chen Y; Cheng QM; Li Y; Luo ZQ Respir Res; 2013 Oct; 14(1):101. PubMed ID: 24098933 [TBL] [Abstract][Full Text] [Related]
14. Attenuation of bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of fibroblast proliferation and collagen production in primary culture. Chen X; Sun R; Hu J; Mo Z; Yang Z; Liao D; Zhong N Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):278-86. PubMed ID: 18684219 [TBL] [Abstract][Full Text] [Related]
15. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis. Huaux F; Liu T; McGarry B; Ullenbruch M; Xing Z; Phan SH J Immunol; 2003 Nov; 171(10):5470-81. PubMed ID: 14607953 [TBL] [Abstract][Full Text] [Related]
16. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity. Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567 [TBL] [Abstract][Full Text] [Related]
17. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis. Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884 [TBL] [Abstract][Full Text] [Related]
18. The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis. Liang C; Li X; Zhang L; Cui D; Quan X; Yang W Exp Mol Pathol; 2015 Oct; 99(2):279-85. PubMed ID: 26216407 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2. Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840 [TBL] [Abstract][Full Text] [Related]